Please use this identifier to cite or link to this item:
|Title:||Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks|
|Citation:||Wei, H., Zhou, S., Li, C., Zhang, J., Wu, J., Huang, M. (2005-10). Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks. Pharmaceutical Research 22 (10) : 1762-1766. ScholarBank@NUS Repository. https://doi.org/10.1007/s11095-005-7095-1|
|Abstract:||Objective. This study was conducted to investigate the thiopurine S-methyltransferase (TPMT) activity distribution and gene mutations in Kazaks, and compared the results with those of other ethnic groups. Methods. Erythrocyte TPMT activity was measured in Kazaks (n = 327) via a validated high-performance liquid chromatography assay. Polymerase chain reaction-based methods were used to analyze three commonly reporter-inactivating mutations: G238C, G460A, and A719G. Results. Unimodal distribution of TPMT activity was found in Kazaks. Six TPMT*3C heterozygotes and two TPMT*3A heterozygotes were found in 327 Kazaks, with allele frequencies of 0.9 and 0.3%, respectively. The subjects with TPMT*3A and TPMT*3C heterogygotes had substantial TPMT activity over the range of 6.40-11.75 U/ml RBC. Conclusion. Unlike in most Caucasians, TPMT*3C is a common mutant allele in Kazaks, whereas TPMT*3A is a rare mutant allele. Further studies are needed to explore the clinical impact of these TPMT mutants to thiopurine therapy in Kazak patients. © 2005 Springer Science + Business Media, Inc.|
|Source Title:||Pharmaceutical Research|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 26, 2018
WEB OF SCIENCETM
checked on Apr 3, 2018
checked on May 11, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.